NUCLEOLARON Trademark
NUCLEOLARON is a USPTO trademark filed by TOAGOSEI CO., LTD.. Status: Registered.
Trademark Facts
| Mark | NUCLEOLARON |
|---|---|
| Serial Number | 97482649 |
| Registration Number | 7061973 |
| Status | Registered |
| Filing Date | 2022-06-30 |
| Registration Date | 2023-05-23 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals) |
| Owner | TOAGOSEI CO., LTD. |
| Attorney of Record | Boris Umansky |
| Prosecution Events | 17 |
| Latest Event | R.PR on 2023-05-23 |
Goods & Services
Reagents for scientific and research use; Chemical reagents, other than for medical or veterinary purpose; Biochemical reagents used for non-medical purposes; Biochemical preparations for scientific purposes; Chemical preparations for transferring molecules, such as peptides, siRNA or DNA, into cells, for use in industry and scientific purposes; Chemicals used in industry and science | Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Medicinal preparations for the treatment of muscular dystrophy, muscle diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, cancer, heart diseases and disorders, and brain diseases and disorders; Pharmaceutical preparations for the treatment of muscular dystrophy, muscle diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, cancer, heart diseases and disorders, and brain diseases and disorders; Pharmaceuticals for the treatment of muscular dystrophy, muscle diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, cancer, heart diseases and disorders, and brain diseases and disorders; Medicines for the treatment of muscular dystrophy, muscle diseases and disorders, neurological diseases and disorders, neuromuscular diseases and disorders, cancer, heart diseases and disorders, and brain diseases and disorders; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Medicinal preparations for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals